Product Description
Etidronic Acid is as a member of the family of drugs known as bisphosphonates, etidronate differs from endogenous pyrophosphate in its resistance to enzymatic hydrolysis. This agent adsorbs to hydroxyapatite cells and reduces the number of osteoclasts, thereby inhibiting abnormal bone resorption. Etidronate may also directly stimulate bone formation by osteoblasts. (NCI) (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Etidronic-acid)
Mechanisms of Action: Bone Resorption Inhibitor, Hydroxyapatite Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intravenous, Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Australia | Canada | Chile | Colombia | Egypt | Germany | Greece | India | Ireland | Italy | Korea | Morocco | New Zealand | Pakistan | Peru | Portugal | Russia | Slovenia | Spain | Sweden | Taiwan | Turkey | United Kingdom | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
10/19/2023 |
News Article |
Etidronate Disodium Market 2023 Latest Trend, Demand and Business Outlook by Top Key Players -Alfa Aesar, Toronto Research Chemicals, Energy Chemical, TCL(shanghai) |
|
10/03/2023 |
News Article |
Etidronic Acid Market (New Report) Size, Share Report 2023-2031 |
|
09/12/2023 |
News Article |
Forecasting the Future Price Outlook for HPMA (Hydroxypropyl Methacrylate) |
|
09/06/2023 |
News Article |
With 11.71% CAGR, Global Hypercalcemia Treatment Market Size Likely to Hit $39.29 Billion by 2031, Share, Growth, Technology Trends & Market Research |